Company profile for Dyve Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Dyve Biosciences created a breakthrough platform technology that broadly enables transdermal drug delivery. Dyve has advanced clinical programs in gout and melasma that demonstrate the power and potential of the technology. Dyve’s platform technology is a simple drug development model. Dyve uses existing drugs with proven safety and efficacy to enable an efficient use of resources and fast development timelines while mitig...
Dyve Biosciences created a breakthrough platform technology that broadly enables transdermal drug delivery. Dyve has advanced clinical programs in gout and melasma that demonstrate the power and potential of the technology. Dyve’s platform technology is a simple drug development model. Dyve uses existing drugs with proven safety and efficacy to enable an efficient use of resources and fast development timelines while mitigating drug development and investor risk.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2545 W Hillcrest Dr Thousand Oaks, California 91360
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/06/01/2454568/0/en/Dyve-Biosciences-Announces-Phase-2-TARGETS-Study-of-DYV702-for-Pain-Associated-with-Acute-Gout-Flares-Showcased-in-Podium-Presentation-at-2022-EULAR-Congress.html

GLOBENEWSWIRE
01 Jun 2022

https://www.globenewswire.com/news-release/2022/06/01/2454188/0/en/Dyve-Biosciences-to-Participate-in-the-BIO-International-Convention.html

GLOBENEWSWIRE
01 Jun 2022

https://www.globenewswire.com/news-release/2022/05/04/2435693/0/en/Dyve-Biosciences-to-Present-at-the-UBS-Global-Healthcare-Conference.html

GLOBENEWSWIRE
04 May 2022

https://www.globenewswire.com/news-release/2022/03/09/2399880/0/en/Dyve-Biosciences-to-Present-at-the-34th-Annual-Roth-Conference.html

GLOBENEWSWIRE
09 Mar 2022

https://www.globenewswire.com/news-release/2022/03/01/2394062/0/en/Dyve-Biosciences-Announces-the-Appointment-of-Nicholas-A-Saccomano-Ph-D-to-its-Scientific-Advisory-Board.html

GLOBENEWSWIRE
01 Mar 2022

https://www.globenewswire.com/news-release/2022/02/03/2378483/0/en/Dyve-Biosciences-Announces-Research-and-Development-Collaboration-with-Moffitt-Cancer-Center.html

GLOBENEWSWIRE
03 Feb 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty